A systematic review of sodium-glucose cotransporter 2 inhibitors and renal profiles among Japanese patients with type 2 diabetes mellitus

被引:0
|
作者
Junichi Mukai
Nakaba Okamura
Yuki Saito
Rie Kubota
机构
[1] Kitasato University,Division of Clinical Pharmacy (Laboratory of Clinical Pharmacy Education) and Research and Education Center for Clinical Pharmacy, School of Pharmacy
关键词
Meta-analysis; Systematic review; Sodium-glucose co-transporter 2 inhibitors; Renal profiles; Type 2 diabetes mellitus; Japanese;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
    Cherney, David Z. I.
    Perkins, Bruce A.
    Soleymanlou, Nima
    Maione, Maria
    Lai, Vesta
    Lee, Alana
    Fagan, Nora M.
    Woerle, Hans J.
    Johansen, Odd Erik
    Broedl, Uli C.
    von Eynatten, Maximilian
    CIRCULATION, 2014, 129 (05) : 587 - 597
  • [42] Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus
    Tung-Sheng Chen
    Teng-Shun Yu
    Cheng-Li Lin
    Chung Y. Hsu
    Wei-Syun Hu
    Journal of Nephrology, 2023, 36 : 713 - 718
  • [43] Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus
    Chen, Tung-Sheng
    Yu, Teng-Shun
    Lin, Cheng-Li
    Hsu, Chung Y.
    Hu, Wei-Syun
    JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 713 - 718
  • [44] Association of sodium-glucose cotransporter 2 inhibitors with the incidence of corneal diseases in type 2 diabetes mellitus
    Tsai, Tsan-Yu
    Yang, Po-Jen
    Chao, Shih-Chun
    Lee, Chia-Yi
    Huang, Jing-Yang
    Yang, Shun-Fa
    Lin, Hung-Yu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (03): : 583 - 592
  • [45] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (05) : 1365 - 1370
  • [46] Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes
    Bea, Sungho
    Jeong, Han Eol
    Kim, Jae Hyeon
    Yu, Oriana Hy
    Azoulay, Laurent
    Shin, Ju-Young
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3451 - +
  • [47] Effect of sodium-glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus
    Imada, Tasuku
    Katakami, Naoto
    Watanabe, Hirotaka
    Nishina, Shuhei
    Sasaki, Shugo
    Takahara, Mitsuyoshi
    Shimomura, Iichiro
    Yamamoto, Tsunehiko
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (07) : 843 - 850
  • [48] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana Hoi Yun
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 349 - 349
  • [50] Utilization of sodium-glucose cotransporter 2 inhibitors on dry eye disease severity in patients with type 2 diabetes mellitus
    Yao, Yen-Po
    Yang, Po-Jen
    Lee, Chia-Yi
    Huang, Jing-Yang
    Yang, Shun-Fa
    Lin, Hung-Yu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (13): : 1705 - 1710